Susan L. Kelley - Net Worth and Insider Trading
Susan L. Kelley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Susan L. Kelley owns 5 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) , Dare Bioscience Inc (DARE) , and Arqule Inc (ARQL) among others .
Click here to see the complete history of Susan L. Kelley’s form 4 insider trades.
Insider Ownership Summary of Susan L. Kelley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2019-07-08 | director |
| DARE | Dare Bioscience Inc | 2014-10-03 | director |
| ARQL | Arqule Inc | 2020-01-16 | director |
 | | 2019-04-02 | director |
| | 2021-02-12 | director |
Susan L. Kelley Trading Performance
Susan L. Kelley Ownership Network
Ownership Network List of Susan L. Kelley
Ownership Network Relation of Susan L. Kelley
Susan L. Kelley Owned Company Details
What does Deciphera Pharmaceuticals Inc do?
Who are the key executives at Deciphera Pharmaceuticals Inc?
Susan L. Kelley is the director of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include SVP & Regulatory & Quality Jama Pitman , Chief Commercial Officer Daniel C. Martin , and Chief Financial Officer Thomas Patrick Kelly .
Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary
Over the past 18 months, Susan L. Kelley made no insider transaction in Deciphera Pharmaceuticals Inc (DCPH). Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 23,797 shares made by Daniel C. Martin , a net sale of 12,184 shares made by Matthew L Sherman , and a net sale of 9,198 shares made by Thomas Patrick Kelly .
In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 105,002 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 95,002 shares.
Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Deciphera Pharmaceuticals Inc Insider Transactions
Susan L. Kelley Mailing Address
Above is the net worth, insider trading, and ownership report for Susan L. Kelley. You might contact Susan L. Kelley via mailing address: C/o Deciphera Pharmaceuticals, Inc., 200 Smith Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
